Mefitel film for radiation dermatitis: it works, why not?

Published Date: 13 Mar 2023

According to the results of a phase 3 trial, the use of silicone film before radiotherapy can reduce the incidence of radiodermatitis, so why not use it?

Read Full News

Latest News

Obesity Drugs Linked to Lower Cancer Risk

Treatment with GLP-1 receptor agonists or dual GLP-1/ GIP receptor agonists is associated with reduced overall and skin cancer risks in people with obesity.

MHRA Strengthens Warnings on Finasteride and Dutasteride

The MHRA has updated product information for finasteride and dutasteride following a review of psychiatric and sexual side effects.

Rise in Global Skin Cancer Burden Projected to Continue

The global skin cancer burden has increased from 1990 to 2023 and is projected to rise through 2050, a database analysis shows.

Skin Cancer Location Potential Predictor of Poor Outcomes

Despite a higher incidence of poor outcomes with squamous cell carcinoma tumors on the scalp, it was the lip and temple that emerged as highest risk after adjustments for other factors.

Ultrafine Water Clusters Reduce Laser-Associated Erythema

A novel technology using nano-sized ultrafine water clusters is associated with significant reduction in the erythema that occurs post-laser treatment, new research shows.

A New Name for PCOS, the Most Common Cause Of Infertility

A disorder that affects 170 million women worldwide and is the leading cause of infertility known as polycystic ovary syndrome, ⁠or PCOS, is being renamed to improve...

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Latest News

Treatment with GLP-1 receptor agonists or dual GLP-1/ GIP receptor agonists is associated with reduced overall and skin cancer risks in people with obesity.

The MHRA has updated product information for finasteride and dutasteride following a review of psychiatric and sexual side effects.

The global skin cancer burden has increased from 1990 to 2023 and is projected to rise through 2050, a database analysis shows.

Despite a higher incidence of poor outcomes with squamous cell carcinoma tumors on the scalp, it was the lip and temple that emerged as highest risk after adjustments for other factors.

A novel technology using nano-sized ultrafine water clusters is associated with significant reduction in the erythema that occurs post-laser treatment, new research shows.

A disorder that affects 170 million women worldwide and is the leading cause of infertility known as polycystic ovary syndrome, ⁠or PCOS, is being renamed to improve...

News All Time

AAD Future Focus: Future Focus from the American Academy of Dermatology

Uneven Access to Biologics in Psoriasis, Study Shows

Black patients on Medicaid less likely to use the newer therapies

Huge Cost Difference for Sunscreens With Same Ingredients, Same SPF Rating

Clothing choices, frequency and consistency of application figure into total cost

White House Details Cause of Trump's Neck Redness

Photos from at least as far back as last week show visible redness on the president's neck

What Cream Is Trump Using on His Neck?

Does the President's annual physical report provide a clue?

CDC Study Warns on Infection-Related Cancers After Organ Transplant

Kaposi sarcoma-associated herpesvirus testing is not routinely performed on donors or recipients

Sentinel Node Biopsy Improves Survival in Melanoma, Meta-Analysis Shows

"Our findings provide the best evidence available," researchers say

Quiz Time: What Caused Trump's Neck Redness?

You passed medical training, now see if you can pass our weekly quiz

Dual Immunotherapy and Liver Perfusion Delays Progression in Uveal Melanoma

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study

GLP-1 Drugs May Benefit Cancer Patients With Brain Lesions

Retrospective study finds link between blockbuster drugs and longer survival

Bimekizumab Safety Holds Up in Long-Term Data

Pooled data from PsA and axSpA extension studies provide early reassurance

Hidradenitis Suppurativa Linked to Higher Risk of Self-Harm, Including Suicide

Twofold higher risk than general population, suicide more often preceded by episode of self-harm

FDA OKs First Drug for Liver Disease-Related Pruritus

Linerixibat approved for cholestatic itch in primary biliary cholangitis

FDA Withdraws Proposal for Tanning Bed Age Limit

Agency cites concerns raised in public comments; dermatologists emphasize risks for young people

'Potential Game Changer' for Psoriasis Gets Green Light From FDA

Oral IL-23 inhibitor icotrokinra achieved near-complete skin clearance in two-thirds of patients

Make the Diagnosis: From a Bone Marrow Transplant to a Huge Rash. What’s Your Diagnosis?

A 49-year-old man with a history of acute myeloid leukemia who received an allogeneic bone marrow transplant 2 weeks prior developed a widespread rash. Can you diagnose the patient?